Document is current
Any future updates will be listed below
-
Authors
Gupta, Pranav
Chatterjee, Manash
Kim, Yeonil
Deschamps, Kathleen
Lemoine, Lieselotte
Van Dyck, Kristien
Matthews, Catherine Zhou
Rottey, Sylvie
Stoch, Aubrey
Lai, Eseng
-
Funding
Funding for this research was provided by:
Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 20 July 2024
First Online: 10 August 2024
Declarations
:
: The study protocol and all amendments were approved by the institutional review board or ethics committee at each participating institution (Medical Ethics Committee UZ Ghent). The study was conducted in accordance with the protocol, its amendments, the ethical principles originating from the Declaration of Helsinki, and Good Clinical Practice guidelines.
: Written informed consent was provided by all patients before enrollment.
: PG, MC, YK, KD, LL, KVD, CZM, AS, and EL are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may hold stock in Merck & Co., Inc., Rahway, NJ, USA.SR reports grants or contracts during the conduct of the trial for which they received payment; speaker fees to their institution from BMS, MSD, Pfizer, and Roche; travel support for Astellas, MSD, and Sanofi; served on an advisory board for Ipsen, J&J, and MSD; serving as a member of a Data Safety Monitoring Board for all industry-driven phase 1 trials in the department (>20/year); and replacing a member of the CTG (commission for reimbursement of drugs in Belgium) every time a COI is requested per voting.
